Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective and Retrospective, Long-Term Observational Study of AVONEX® and Rebif® to Determine the Efficacy, Tolerability, and Safety in Subjects With Relapsing Multiple Sclerosis (MS)

NCT00599274 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00599274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00599274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective and Retrospective, Long-Term Observational Study of AVONEX® and Rebif® to Determine the Efficacy, Tolerability, and Safety in Subjects With Relapsing Multiple Sclerosis (MS)
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
August 31, 2002
Completion date
May 31, 2003
Enrollment
136 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis